Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy.
Front Pharmacol
; 14: 1180826, 2023.
Article
in En
| MEDLINE
| ID: mdl-37408761
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Germany
Country of publication:
Switzerland